Anti-cancer Antibody Trastuzumab-Melanotransferrin Conjugate (BT2111) for the Treatment of Metastatic HER2+ Breast Cancer Tumors in the Brain: an In-Vivo Study
Document Details
- Document Type
- Pub Defense Publication
- Publication Date
- Aug 15, 2016
- Source ID
- 10.1007/s11095-016-2015-0
Entities
People
- Chris E. Adkins
- Evelina Rubinchik
- Mei Mei Tian
- Mohamed Afroz
- Mohamed Ismail Nounou
- Paul R. Lockman
- Reinhard Gabathuler
- Tim Vitalis
- Tori B. Terrell-hall
Organizations
- National Cancer Institute
- National Institute of General Medical Sciences
- United States Department of Defense